Skip to content

Discovery Programs

R&D Pipeline

Gubra has a strong R&D pipeline for target discovery and peptide drug discovery. Our focus is on metabolic, fibrotic, and inflammatory diseases, where we are scientific experts.

Why Gubra?
  • Innovative and data-driven approach
  • Expert guidance in target and diseases
  • High quality data, integrity, speed and flexibility
  • Professional and agile project organization

Consult with Lise Biehl Rudkjær

Senior Director, Business Development

Choose the right, trustworthy discovery partner.

Healthy mix of internal & partnered programs

Gubra’s R&D Pipeline

Gubra´s R&D pipeline is a healthy mix of partnered programs and internal programs aimed for partnering now or at a later stage. Please get in contact if you would like to hear more.

Our scientific expertise and AI-driven platforms are key to our strong pipeline.

We combine our AI and machine-learning platforms with cutting-edge science to quickly move forward our programs. Our agile approach and complete in-house capabilities ensures speed and high data quality.
Niels Vrang, CSO (co-founder)

Key figures


Active Partnerships
  • Current collaboration partners: Boehringer Ingelheim and Hemab
  • A longterm trusted alliance partner


Clinical Development
  • Four projects in clinical development phase
  • Two projects in Phase I


Open Projects
  • A diverse portfolio of internal projects
  • Ready to be partnered now or later

Related pages

For further information

Contact us


Hørsholm Kongevej 11B
2970 Hørsholm

+45 3152 ­2650

Back To Top